ProPhase Labs, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Share (Tables)

Earnings (Loss) Per Share (Tables)

6 Months Ended

Jun. 30, 2016

Schedule of Reconciliation of Applicable Numerators and Denominators of Income Statement Periods

A reconciliation of the applicable numerators and denominators of the income statement periods presented, as reflected in the results of continuing operations, is as follows (in thousands, except per share amounts):

	Three Months Ended								Three Months Ended								Six Months Ended								Six Months Ended
	June 30, 2016								June 30, 2015								June 30, 2016								June 30, 2015
	Loss			Shares		EPS			Loss			Shares		EPS			Loss			Shares		EPS			Loss			Shares		EPS
Basic loss per share	$	(1,127	)		17,081	$	(0.06	)	$	(1,566	)		16,020	$	(0.10	)	$	(2,463	)		17,081	$	(0.14	)	$	(2,946	)		15,956	$	(0.18	)

Dilutives:
Options		-			-		-			-			-		-			-			-		-			-			-		-

Diluted loss per share	$	(1,127	)		17,081	$	(0.06	)	$	(1,566	)		16,020	$	(0.10	)	$	(2,463	)		17,081	$	(0.14	)	$	(2,946	)		15,956	$	(0.18	)